Free Trial

Charles River Laboratories International (CRL) SEC Filings & 10K Form

Charles River Laboratories International logo
$189.91 +0.58 (+0.31%)
(As of 11:47 AM ET)

Recent Charles River Laboratories International SEC Filings

DateFilerForm TypeView
12/13/2024
3:42 PM
Charles River Laboratories International (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2024
5:21 PM
Barbo William D (Reporting)
Charles River Laboratories International (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2024
4:31 PM
BlackRock, Inc. (Filed by)
Charles River Laboratories International (Subject)
Form SC 13G/A
11/08/2024
9:52 AM
Charles River Laboratories International (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G
11/07/2024
3:23 PM
Charles River Laboratories International (Subject)
WALLMAN RICHARD F (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/06/2024
8:16 AM
Charles River Laboratories International (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2024
6:21 AM
Charles River Laboratories International (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/22/2024
2:24 PM
BlackRock, Inc. (Filed by)
Charles River Laboratories International (Subject)
Form SC 13G/A
08/13/2024
3:17 PM
Charles River Laboratories International (Issuer)
FOSTER JAMES C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2024
3:13 PM
Charles River Laboratories International (Issuer)
LaPlume Joseph W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2024
12:34 PM
Charles River Laboratories International (Subject)
LaPlume Joseph W (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/07/2024
8:15 AM
Charles River Laboratories International (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/07/2024
6:21 AM
Charles River Laboratories International (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/04/2024
3:46 PM
Charles River Laboratories International (Issuer)
LaPlume Joseph W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
3:17 PM
Charles River Laboratories International (Issuer)
Pease Flavia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
3:37 PM
Charles River Laboratories International (Issuer)
LaPlume Joseph W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2024
7:05 PM
Barbo William D (Reporting)
Charles River Laboratories International (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2024
7:18 PM
Charles River Laboratories International (Issuer)
Parisotto Shannon M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2024
6:56 PM
Charles River Laboratories International (Issuer)
Pease Flavia (Reporting)
Form 4/A
05/30/2024
7:02 PM
Charles River Laboratories International (Issuer)
Creamer Victoria L (Reporting)
Form 4/A
05/30/2024
6:47 PM
Barbo William D (Reporting)
Charles River Laboratories International (Issuer)
Form 4/A
05/30/2024
5:58 PM
Charles River Laboratories International (Issuer)
FOSTER JAMES C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
4:51 PM
Charles River Laboratories International (Issuer)
Knell Michael Gunnar (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
4:46 PM
Charles River Laboratories International (Issuer)
Girshick Birgit (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
4:48 PM
Charles River Laboratories International (Issuer)
Creamer Victoria L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
4:34 PM
Charles River Laboratories International (Issuer)
Knell Michael Gunnar (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
4:38 PM
Charles River Laboratories International (Issuer)
Pease Flavia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
4:08 PM
Charles River Laboratories International (Issuer)
Creamer Victoria L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
4:10 PM
Charles River Laboratories International (Issuer)
Knell Michael Gunnar (Reporting)
Form 4/A
05/29/2024
3:05 PM
Charles River Laboratories International (Filer)
Form SD
Specialized Disclosure Report  
05/28/2024
4:42 PM
Barbo William D (Reporting)
Charles River Laboratories International (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
4:25 PM
Charles River Laboratories International (Issuer)
Girshick Birgit (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
4:29 PM
Charles River Laboratories International (Issuer)
LaPlume Joseph W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
4:32 PM
Charles River Laboratories International (Issuer)
Parisotto Shannon M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2024
3:35 PM
Charles River Laboratories International (Issuer)
MASSARO GEORGE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2024
6:24 PM
Andrews Nancy C (Reporting)
Charles River Laboratories International (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2024
6:30 PM
Charles River Laboratories International (Issuer)
WILSON VIRGINIA M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2024
4:47 PM
Charles River Laboratories International (Issuer)
Thompson Craig B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2024
4:52 PM
Charles River Laboratories International (Issuer)
MACKAY MARTIN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2024
4:38 PM
BERTOLINI ROBERT J (Reporting)
Charles River Laboratories International (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2024
4:42 PM
Charles River Laboratories International (Issuer)
WALLMAN RICHARD F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
DeFi Coin on Verge of Breakout! (Ad)

The blueprint for millionaires is here. Don't let this be the missed opportunity you regret for years.

Claim your FREE book now before it's too late!
05/15/2024
4:27 PM
Charles River Laboratories International (Issuer)
MASSARO GEORGE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2024
4:30 PM
Charles River Laboratories International (Issuer)
Llado George Sr. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2024
4:34 PM
Charles River Laboratories International (Issuer)
Kemps-Polanco Reshema (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
3:49 PM
Charles River Laboratories International (Issuer)
LaPlume Joseph W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2024
10:30 AM
Charles River Laboratories International (Subject)
LaPlume Joseph W (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/09/2024
3:20 PM
Charles River Laboratories International (Filer)
Form S-3ASR
05/09/2024
8:17 AM
Charles River Laboratories International (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2024
6:31 AM
Charles River Laboratories International (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/24/2024
6:30 AM
Charles River Laboratories International (Filer)
Form DEFA14A
03/29/2024
7:00 AM
Charles River Laboratories International (Filer)
Form DEF 14A
03/29/2024
7:01 AM
Charles River Laboratories International (Filer)
Form ARS
03/25/2024
5:48 PM
Barbo William D (Reporting)
Charles River Laboratories International (Issuer)
Form 4/A
03/25/2024
5:52 PM
Charles River Laboratories International (Issuer)
Parisotto Shannon M (Reporting)
Form 4/A
03/25/2024
5:58 PM
Charles River Laboratories International (Issuer)
FOSTER JAMES C (Reporting)
Form 4/A
03/25/2024
6:00 PM
Charles River Laboratories International (Issuer)
Creamer Victoria L (Reporting)
Form 4/A
03/25/2024
4:49 PM
Charles River Laboratories International (Issuer)
Knell Michael Gunnar (Reporting)
Form 4/A
03/25/2024
4:52 PM
Charles River Laboratories International (Issuer)
Girshick Birgit (Reporting)
Form 4/A
03/25/2024
4:55 PM
Charles River Laboratories International (Issuer)
LaPlume Joseph W (Reporting)
Form 4/A
03/11/2024
3:42 PM
Charles River Laboratories International (Issuer)
Knell Michael Gunnar (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
1:34 PM
Charles River Laboratories International (Subject)
Knell Michael Gunnar (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/05/2024
3:54 PM
Charles River Laboratories International (Issuer)
Knell Michael Gunnar (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
11:47 AM
Charles River Laboratories International (Subject)
Knell Michael Gunnar (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/01/2024
4:37 PM
Charles River Laboratories International (Issuer)
Creamer Victoria L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
2:14 PM
Charles River Laboratories International (Subject)
Creamer Victoria L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/29/2024
11:42 AM
Charles River Laboratories International (Subject)
Parisotto Shannon M (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/23/2024
3:57 PM
Barbo William D (Reporting)
Charles River Laboratories International (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2024
10:09 AM
Barbo William D (Reporting)
Charles River Laboratories International (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/20/2024
4:28 PM
Charles River Laboratories International (Issuer)
FOSTER JAMES C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2024
4:32 PM
Charles River Laboratories International (Issuer)
Parisotto Shannon M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
5:37 PM
Charles River Laboratories International (Issuer)
Girshick Birgit (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2024
10:02 AM
Charles River Laboratories International (Subject)
LaPlume Joseph W (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/14/2024
8:19 AM
Charles River Laboratories International (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2024
6:30 AM
Charles River Laboratories International (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/05/2024
7:31 PM
Charles River Laboratories International (Issuer)
Kemps-Polanco Reshema (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
6:35 PM
Charles River Laboratories International (Issuer)
Parisotto Shannon M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
6:14 PM
Charles River Laboratories International (Issuer)
Girshick Birgit (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
4:34 PM
Charles River Laboratories International (Issuer)
Girshick Birgit (Reporting)
Form 4/A
01/31/2024
4:26 PM
Charles River Laboratories International (Issuer)
Creamer Victoria L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
4:28 PM
Charles River Laboratories International (Issuer)
LaPlume Joseph W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
4:31 PM
Charles River Laboratories International (Issuer)
Knell Michael Gunnar (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
4:23 PM
Barbo William D (Reporting)
Charles River Laboratories International (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
3:59 PM
Charles River Laboratories International (Issuer)
FOSTER JAMES C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
4:03 PM
Charles River Laboratories International (Issuer)
FOSTER JAMES C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2024
3:34 PM
Charles River Laboratories International (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/24/2024
1:27 PM
BlackRock Inc. (Filed by)
Charles River Laboratories International (Subject)
Form SC 13G/A
01/16/2024
3:32 PM
Charles River Laboratories International (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/11/2024
3:09 PM
Charles River Laboratories International (Issuer)
Girshick Birgit (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NYSE:CRL) was last updated on 12/18/2024 by MarketBeat.com Staff
From Our Partners